269 related articles for article (PubMed ID: 17063173)
21. Shiga toxin B-subunit binds to the chaperone BiP and the nucleolar protein B23.
Falguières T; Johannes L
Biol Cell; 2006 Feb; 98(2):125-34. PubMed ID: 15853775
[TBL] [Abstract][Full Text] [Related]
22. Endothelial heterogeneity in Shiga toxin receptors and responses.
Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
[TBL] [Abstract][Full Text] [Related]
23. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy.
Luginbuehl V; Meier N; Kovar K; Rohrer J
Biotechnol Adv; 2018; 36(3):613-623. PubMed ID: 29432805
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor alpha increases human cerebral endothelial cell Gb3 and sensitivity to Shiga toxin.
Eisenhauer PB; Chaturvedi P; Fine RE; Ritchie AJ; Pober JS; Cleary TG; Newburg DS
Infect Immun; 2001 Mar; 69(3):1889-94. PubMed ID: 11179369
[TBL] [Abstract][Full Text] [Related]
25. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells.
Falguières T; Römer W; Amessou M; Afonso C; Wolf C; Tabet JC; Lamaze C; Johannes L
FEBS J; 2006 Nov; 273(22):5205-18. PubMed ID: 17059464
[TBL] [Abstract][Full Text] [Related]
26. Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.
Te Loo DM; Monnens L; van der Velden T; Karmali M; van den Heuvel L; van Hinsbergh V
Pediatr Nephrol; 2006 Dec; 21(12):1815-23. PubMed ID: 16944213
[TBL] [Abstract][Full Text] [Related]
27. The epithelial cell cytoskeleton and intracellular trafficking. I. Shiga toxin B-subunit system: retrograde transport, intracellular vectorization, and more.
Johannes L
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G1-7. PubMed ID: 12065285
[TBL] [Abstract][Full Text] [Related]
28. Shiga toxin and its use in targeted cancer therapy and imaging.
Engedal N; Skotland T; Torgersen ML; Sandvig K
Microb Biotechnol; 2011 Jan; 4(1):32-46. PubMed ID: 21255370
[TBL] [Abstract][Full Text] [Related]
29. Efficient endosome-to-Golgi transport of Shiga toxin is dependent on dynamin and clathrin.
Lauvrak SU; Torgersen ML; Sandvig K
J Cell Sci; 2004 May; 117(Pt 11):2321-31. PubMed ID: 15126632
[TBL] [Abstract][Full Text] [Related]
30. In vivo tumor targeting by the B-subunit of shiga toxin.
Viel T; Dransart E; Nemati F; Henry E; Thézé B; Decaudin D; Lewandowski D; Boisgard R; Johannes L; Tavitian B
Mol Imaging; 2008; 7(6):239-47. PubMed ID: 19123994
[TBL] [Abstract][Full Text] [Related]
31. [Retrograde transport of Shiga toxin 1 in human renal tubular epithelial cells].
Kiyokawa N; Fujimoto J
Nihon Rinsho; 2002 Jun; 60(6):1095-100. PubMed ID: 12078079
[TBL] [Abstract][Full Text] [Related]
32. A real-time cell-binding assay reveals dynamic features of STxB-Gb3 cointernalization and STxB-mediated cargo delivery into cancer cells.
Encarnação JC; Napolitano V; Opassi G; Danielson UH; Dubin G; Popowicz GM; Munier-Lehmann H; Buijs J; Andersson K; Björkelund H
FEBS Lett; 2020 Aug; 594(15):2406-2420. PubMed ID: 32473599
[TBL] [Abstract][Full Text] [Related]
33. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells.
O'Loughlin EV; Robins-Browne RM
Microbes Infect; 2001 May; 3(6):493-507. PubMed ID: 11377211
[TBL] [Abstract][Full Text] [Related]
34. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
[TBL] [Abstract][Full Text] [Related]
35. Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum.
Johannes L; Pezo V; Mallard F; Tenza D; Wiltz A; Saint-Pol A; Helft J; Antony C; Benaroch P
Traffic; 2003 May; 4(5):323-32. PubMed ID: 12713660
[TBL] [Abstract][Full Text] [Related]
36. The effects of the carboxyl-terminus amino acids of the Shiga toxin B-subunit on retrograde transport.
Liu D; Fan Y; Li J; Gao X; Hao M; Xue H; Tai G
Mol Med Rep; 2012 Jul; 6(1):220-6. PubMed ID: 22552548
[TBL] [Abstract][Full Text] [Related]
37. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
Selyunin AS; Mukhopadhyay S
Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
[TBL] [Abstract][Full Text] [Related]
38. Pathways followed by ricin and Shiga toxin into cells.
Sandvig K; Grimmer S; Lauvrak SU; Torgersen ML; Skretting G; van Deurs B; Iversen TG
Histochem Cell Biol; 2002 Feb; 117(2):131-41. PubMed ID: 11935289
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of shiga toxin cytotoxicity in human renal cortical epithelial cells by nitrobenzylthioinosine.
Sekino T; Kiyokawa N; Taguchi T; Ohmi K; Nakajima H; Suzuki T; Furukawa S; Nakao H; Takeda T; Fujimoto J
J Infect Dis; 2002 Mar; 185(6):785-96. PubMed ID: 11920296
[TBL] [Abstract][Full Text] [Related]
40. Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum?
Johannes L; Goud B
Trends Cell Biol; 1998 Apr; 8(4):158-62. PubMed ID: 9695830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
